Searched for
BIOCON MALAYSIA
Biocon drops 4% as USFDA issues form 483 for 3 sitesAs per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when an in...
Biocon Biologics receives observations from USFDA: BioconThe USFDA conducted three on-site inspections of Biocon Biologics' seven manufacturing facilities spanning two sites in Bengaluru, India an...
Biocon Biologics' arm gets USD 90 mn contract from Malaysian government for supply of insulinsBiocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...
Biocon Biologics wins $90 mn contract from Malaysia to supply human insulinBiocon has a insulins manufacturing facility is Malaysia at Johor which has been approved by the National Pharmaceutical Regulatory Authori...
Biocon says probe on Malaysia manufacturing unit ends“This is to inform you that Biocon Sdn Bhd, a subsidiary of Biocon, has received the EIR from the USFDA for the pre-approval inspection of ...
Biocon gets 3 USFDA observations for insulin facility in MalaysiaUSFDA had conducted a pre-approval inspection of Biocon's subsidiary Biocon Sdn BHd's manufacturing facility in Malaysia for Insulin Glargi...
Biocon's Malaysian arm gets EU GMP certification for insulin manufacturing facilityThe integrated insulins facility in Malaysia manufactures drug substance and drug products in vials, cartridges, and insulin delivery devic...
USFDA issues 12 observations for 3 Biocon units in MalaysiaUS health regulator has issued 12 observations after the inspection of three of Biocon's units in Malaysia.
Biocon Q3 net profit dips 46% to Rs 91.9 croreConsolidated revenue from operations of the company stood at Rs 1,057.9 crore for the quarter under consideration as against Rs 1,044.4 cro...
Biocon's insulin facility in Malaysia clears inspections for European marketThe facility, set up with an investment of $275 million, is designed to manufacture recombinant human insulin and insulin analogs for the g...
Biocon bags Rs 460-crore contract from MalaysiaThe drug, manufactured by Biocon at its large scale biopharmaceutical facility in Johor, Malaysia, is the country's first locally manufactu...
Malaysian facility to be commercialised in H2 FY17: BioconInitially, the products from the facility will cater to local markets but they would be taken gradually to global markets, Kiran Mazumdar-S...
Biocon Ltd gives Malaysian company CCM Pharmaceuticals licence for insulin distributionAccording to CCM, Malaysia’s anti-diabetic market is growing at 10.6 per cent annually. In 2011, it was worth RM 277 million.
- Biocon and Manipal education Malaysia ink pact for talent management program
The MOU states students of Manipal International University will be trained and employed in Biocon's Malaysian factory.
- Biocon seals Rs 1,550 cr pact with Pfizer
The agreement includes the commercialisation of Biocon’s biosimilar versions of insulin and insulin analog products: recombinant human insu...
- Malaysia offers good incentives for Indian biotech companies
Malaysia is keen to work with Indian companies venturing into biotechnology as it has offered attractive incentives and infrastructure to t...
- Biocon LTD signs MoU with Malaysian-based BiotechCorp
Biocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investmen...